Development and comparative evaluation of SARS-CoV-2 S-RBD and N based ELISA tests in various African endemic settings

被引:7
作者
Benabdessalem, Chaouki [1 ,2 ]
Ben Hamouda, Wafa [1 ,2 ]
Marzouki, Soumaya [1 ]
Faye, Rokhaya [3 ]
Mbow, Adji Astou [3 ]
Diouf, Babacar [3 ]
Ndiaye, Oumar [3 ]
Dia, Ndongo [3 ]
Faye, Ousmane [3 ]
Sall, Amadou A. [3 ]
Diagne, Cheikh Tidiane [3 ]
Amellal, Houda [4 ]
Ezzikouri, Sayeh [4 ]
Mioramalala, Diary Juliannie Ny [5 ]
Randrianarisaona, Fanirisoa [5 ]
Trabelsi, Khaled [2 ,6 ]
Boumaiza, Mohamed [2 ,6 ]
Ben Hamouda, Sonia [2 ]
Ouni, Rym [2 ]
Bchiri, Soumaya [2 ]
Chaaban, Amani [2 ,6 ]
Gdoura, Mariem [7 ]
Gorgi, Yousr [2 ,8 ]
Sfar, Imen [2 ,8 ]
Yalaoui, Sadok [2 ,9 ]
Ben Khelil, Jalila [2 ,10 ]
Hamzaoui, Agnes [2 ,11 ]
Abdallah, Meya [2 ,12 ]
Cherif, Yosra [2 ,12 ]
Petres, Stephane [13 ]
Mok, Chris Ka Pun [14 ,15 ]
Escrioum, Nicolas [13 ]
Quesney, Sebastien [13 ]
Dellagi, Koussay [13 ,16 ]
Schoenhals, Matthieu [5 ]
Sarih, M'hammed [4 ]
Vigan-Womas, Ines [3 ]
Bettaieb, Jihene [1 ,2 ]
Rourou, Samia [2 ,6 ]
Barbouche, Mohamed Ridha [1 ,2 ,17 ]
Ben Ahmed, Melika [1 ,2 ]
机构
[1] Inst Pasteur Tunis, Lab Transmiss Control & Immunobiol Infect, Tunis, Tunisia
[2] Univ Tunis Manar, Tunis, Tunisia
[3] Inst Pasteur, Dakar, Senegal
[4] Inst Pasteur Maroc, Dept Parasitol & Vectorial Dis, Casablanca, Morocco
[5] Inst Pasteur Madagascar, Immunol Infect Dis, Antananarivo, Madagascar
[6] Inst Pasteur Tunis, Lab Mol Microbiol Vaccinol & Biotechnol Dev, Tunis, Tunisia
[7] Inst Pasteur Tunis, Lab Clin Virol, Tunis, Tunisia
[8] Charles Nicolle Hosp, Lab Immunol, Tunis, Tunisia
[9] Abderrahmen Mami Univ Hosp, Lab Immunol, Ariana, Tunisia
[10] Abderrahmen Mami Univ Hosp, Intens Care Unit, Life Sci Dept, Biotechnol Programme, Ariana, Tunisia
[11] Abderrahmen Mami Univ Hosp, Pneumol Dept, Ariana, Tunisia
[12] Yasminette Hosp, Dept internal Med, Ben Arous, Tunisia
[13] Inst Pasteur Paris, Paris, France
[14] Univ Hong Kong, Sch Publ Hlth, HKU Pasteur Res Pole, Hong Kong, Peoples R China
[15] Chinese Univ Hong Kong, Jockey Club Sch Publ Hlth & Primary Care, Hong Kong, Peoples R China
[16] Inst Pasteur, Pasteur Network, Paris, France
[17] Arabian Gulf Univ, Coll Med & Med Sci, Dept Microbiol Immunol & Infect Dis, Manama, Bahrain
关键词
ELISA; Nucleoprotein N; S-RBD; COVID-19; Multicentric validation; Endemic African settings;
D O I
10.1016/j.diagmicrobio.2023.115903
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Management of the COVID-19 pandemic relies on molecular diagnostic methods supported by serological tools. Herein, we developed S-RBD-and N-based ELISA assays useful for infection rate surveillance as well as the follow-up of acquired protective immunity against SARS-CoV-2. ELISA assays were optimized using COVID-19 Tunisian patients' sera and prepandemic controls. Assays were further validated in 3 African coun-tries with variable endemic settings. The receiver operating curve was used to evaluate the assay performances. The N-and S-RBD-based ELISA assays performances, in Tunisia, were very high (AUC: 0.966 and 0.98, respectively, p < 0.0001). Cross-validation analysis showed similar performances in different settings. Cross-reactivity, with malaria infection, against viral antigens, was noticed. In head-to-head comparisons with dif-ferent commercial assays, the developed assays showed high agreement. This study demonstrates, the added value of the developed serological assays in low-income countries, particularly in ethnically diverse popula-tions with variable exposure to local endemic infectious diseases.(c) 2023 Elsevier Inc. All rights reserved.
引用
收藏
页数:7
相关论文
共 29 条
[1]   SARS-CoV-2 S1 and N-based serological assays reveal rapid seroconversion and induction of specific antibody response in COVID-19 patients [J].
Algaissi, Abdullah ;
Alfaleh, Mohamed A. ;
Hala, Sharif ;
Abujamel, Turki S. ;
Alamri, Sawsan S. ;
Almahboub, Sarah A. ;
Alluhaybi, Khalid A. ;
Hobani, Haya, I ;
Alsulaiman, Reem M. ;
AlHarbi, Rahaf H. ;
ElAssouli, M-Z Aki ;
Alhabbab, Rowa Y. ;
AlSaieedi, Ahdab A. ;
Abdulaal, Wesam H. ;
Al-Somali, Afrah A. ;
Alofi, Fadwa S. ;
Khogeer, Asim A. ;
Alkayyal, Almohanad A. ;
Mahmoud, Ahmad Bakur ;
Almontashiri, Naif A. M. ;
Pain, Arnab ;
Hashem, Anwar M. .
SCIENTIFIC REPORTS, 2020, 10 (01)
[2]   A comprehensive, longitudinal analysis of humoral responses specific to four recombinant antigens of SARS-CoV-2 in severe and non-severe COVID-19 patients [J].
Chen, Yuxin ;
Tong, Xin ;
Li, Yang ;
Gu, Bin ;
Yan, Jiawei ;
Liu, Yong ;
Shen, Han ;
Huang, Rui ;
Wu, Chao .
PLOS PATHOGENS, 2020, 16 (09)
[3]   Antibodies against the SARS-CoV-2 S1-RBD cross-react with dengue virus and hinder dengue pathogenesis [J].
Cheng, Yi-Ling ;
Chao, Chiao-Hsuan ;
Lai, Yen-Chung ;
Hsieh, Kun-Han ;
Wang, Jen-Ren ;
Wan, Shu-Wen ;
Huang, Hong-Jyun ;
Chuang, Yung-Chun ;
Chuang, Woei-Jer ;
Yeh, Trai-Ming .
FRONTIERS IN IMMUNOLOGY, 2022, 13
[4]   COVID-19 in Tunisia (North Africa): Seroprevalence of SARS-CoV-2 in the General Population of the Capital City Tunis [J].
Cherif, Ines ;
Kharroubi, Ghassen ;
Chaabane, Sana ;
Yazidi, Rihab ;
Dellagi, Mongi ;
Snoussi, Mohamed Ali ;
Salem, Sadok ;
Marzouki, Soumaya ;
Rebai, Wafa Kammoun ;
Rourou, Samia ;
Dellagi, Koussay ;
Barbouche, Mohamed Ridha ;
Benabdessalem, Chaouki ;
Ben Ahmed, Melika ;
Bettaieb, Jihene .
DIAGNOSTICS, 2022, 12 (04)
[5]   Rapid High-Yield Production of Functional SARS-CoV-2 Receptor Binding Domain by Viral and Non-Viral Transient Expression for Pre-Clinical Evaluation [J].
Farnos, Omar ;
Venereo-Sanchez, Alina ;
Xu, Xingge ;
Chan, Cindy ;
Dash, Shantoshini ;
Chaabane, Hanan ;
Sauvageau, Janelle ;
Brahimi, Fouad ;
Saragovi, Uri ;
Leclerc, Denis ;
Kamen, Amine A. .
VACCINES, 2020, 8 (04) :1-20
[6]  
Fehr AR, 2015, METHODS MOL BIOL, V1282, P1, DOI 10.1007/978-1-4939-2438-7_1
[7]   A comparison of four serological assays for detecting anti-SARS-CoV-2 antibodies in human serum samples from different populations [J].
Grzelak, Ludivine ;
Temmam, Sarah ;
Planchais, Cyril ;
Demeret, Caroline ;
Tondeur, Laura ;
Huon, Christele ;
Guivel-Benhassine, Florence ;
Staropoli, Isabelle ;
Chazal, Maxime ;
Dufloo, Jeremy ;
Planas, Delphine ;
Buchrieser, Julian ;
Rajah, Maaran Michael ;
Robinot, Remy ;
Porrot, Francoise ;
Albert, Melanie ;
Chen, Kuang-Yu ;
Crescenzo-Chaigne, Bernadette ;
Donati, Flora ;
Anna, Francois ;
Souque, Philippe ;
Gransagne, Marion ;
Bellalou, Jacques ;
Nowakowski, Mireille ;
Backovic, Marija ;
Bouadma, Lila ;
Le Fevre, Lucie ;
Le Hingrat, Quentin ;
Descamps, Diane ;
Pourbaix, Annabelle ;
Laouenan, Cedric ;
Ghosn, Jade ;
Yazdanpanah, Yazdan ;
Besombes, Camille ;
Jolly, Nathalie ;
Pellerin-Fernandes, Sandrine ;
Cheny, Olivia ;
Ungeheuer, Marie-Noelle ;
Mellon, Guillaume ;
Morel, Pascal ;
Rolland, Simon ;
Rey, Felix A. ;
Behillil, Sylvie ;
Enouf, Vincent ;
Lemaitre, Audrey ;
Creach, Marie-Aude ;
Petres, Stephane ;
Escriou, Nicolas ;
Charneau, Pierre ;
Fontanet, Arnaud .
SCIENCE TRANSLATIONAL MEDICINE, 2020, 12 (559)
[8]   Characteristics of SARS-CoV-2 and COVID-19 [J].
Hu, Ben ;
Guo, Hua ;
Zhou, Peng ;
Shi, Zheng-Li .
NATURE REVIEWS MICROBIOLOGY, 2021, 19 (03) :141-154
[9]   Characteristics of Anti-SARS-CoV-2 Antibodies in Recovered COVID-19 Subjects [J].
Huynh, Angela ;
Arnold, Donald M. ;
Smith, James W. ;
Moore, Jane C. ;
Zhang, Ali ;
Chagla, Zain ;
Harvey, Bart J. ;
Stacey, Hannah D. ;
Ang, Jann C. ;
Clare, Rumi ;
Ivetic, Nikola ;
Chetty, Vasudhevan T. ;
Bowdish, Dawn M. E. ;
Miller, Matthew S. ;
Kelton, John G. ;
Nazy, Ishac .
VIRUSES-BASEL, 2021, 13 (04)
[10]   SARS-CoV-2 and Plasmodium falciparum common immunodominant regions may explain low COVID-19 incidence in the malaria-endemic belt [J].
Iesa, M. A. M. ;
Osman, M. E. M. ;
Hassan, M. A. ;
Dirar, A. I. A. ;
Abuzeid, N. ;
Mancuso, J. J. ;
Pandey, R. ;
Mohammed, A. A. ;
Borad, M. J. ;
Babiker, H. M. ;
Konozy, E. H. E. .
NEW MICROBES AND NEW INFECTIONS, 2020, 38